Advice
in the absence of a submission from the holder of the marketing authorisation:
eszopiclone (Lunivia®) is not recommended for use within NHSScotland.
Indication under review: treatment of insomnia, in adults, usually for short-term duration.
The holder of the marketing authorisation has not made a submission to SMC regarding this
product in this indication. As a result, we cannot recommend its use within NHSScotland.
Download detailed advice190KB (PDF)
Medicine details
- Medicine name:
- eszopiclone (Lunivia)
- SMC ID:
- SMC2922
- Indication:
Treatment of insomnia, in adults, usually for short-term duration
- Pharmaceutical company
- Axunio Pharma GmbH
- BNF chapter
- Central nervous system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 April 2026